Found: 12
Select item for more details and to access through your institution.
High-risk lymph node ratio predicts worse prognosis in patients with locally advanced oral cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33080-8
- By:
- Publication type:
- Article
Rosai-Dorfman disease in maxillofacial region: case report and review of literature.
- Published in:
- China Journal of Oral & Maxillofacial Surgery, 2013, v. 11, n. 1, p. 85
- By:
- Publication type:
- Article
Computed tomographic features of adenoid cystic carcinoma in the palate.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma.
- Published in:
- Journal of Nanobiotechnology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12951-021-00901-9
- By:
- Publication type:
- Article
Experimental investigation of vincristine on chemosensitivity through Stathmin regulation in oral squamous cell carcinoma.
- Published in:
- Shanghai Journal of Stomatology, 2022, v. 31, n. 1, p. 1, doi. 10.19349/j.sjos.2022.01.001
- By:
- Publication type:
- Article
Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome.
- Published in:
- Cancer Communications, 2021, v. 41, n. 3, p. 279, doi. 10.1002/cac2.12136
- By:
- Publication type:
- Article
Elevated growth differentiating factor 15 expression predicts long-term benefit of docetaxel, cisplatin and 5-fluorouracil induction chemotherapy in patients with oral cancer.
- Published in:
- Oncology Letters, 2018, v. 15, n. 5, p. 8118, doi. 10.3892/ol.2018.8324
- By:
- Publication type:
- Article
Mechanism of sensitivity to cisplatin, docetaxel, and 5‐fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression.
- Published in:
- Cancer Science, 2022, v. 113, n. 2, p. 478, doi. 10.1111/cas.15218
- By:
- Publication type:
- Article
Stathmin guides personalized therapy in oral squamous cell carcinoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 4, p. 1303, doi. 10.1111/cas.14323
- By:
- Publication type:
- Article
Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI–TOF–MS Analysis.
- Published in:
- Proteomics - Clinical Applications, 2018, v. 12, n. 5, p. 1, doi. 10.1002/prca.201700180
- By:
- Publication type:
- Article